Clinical Trial

Platelet-Rich Plasma for Peyronie's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-05.
Status change: Not Yet Recruiting → Recruiting 2025-08-11
Trial Details
NCT Number NCT07117955
Lead Sponsor Herlev Hospital
Conditions Peyronies Disease
Enrollment 84 participants
Start Date 2025-09-20
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-14